Myeloid-derived growth factor in diseases: structure, function and mechanisms.
Peng ChenXiaohui HuangWeiwen LiWeixing WenYue CaoJiahuan LiYuli HuangYunzhao HuPublished in: Molecular medicine (Cambridge, Mass.) (2024)
Myeloid-derived growth factor (MYDGF) is a novel secreted protein with potent antiapoptotic and tissue-repairing properties that is present in nearly 140 human tissues and cell lines, with the highest abundance in the oral epithelium and skin. Initially, MYDGF was found in bone marrow-derived monocytes and macrophages for cardioprotection and repair after myocardial infarction. Subsequent studies have shown that MYDGF plays an important role in other cardiovascular diseases (e.g., atherosclerosis and heart failure), metabolic disorders, renal disease, autoimmune/inflammatory disorders, and cancers. Although the underlying mechanisms have not been fully explored, the role of MYDGF in health and disease may involve cell apoptosis and proliferation, tissue repair and regeneration, anti-inflammation, and glycolipid metabolism regulation. In this review, we summarize the current progress in understanding the role of MYDGF in health and disease, focusing on its structure, function and mechanisms. The graphical abstract shows the current role of MYDGF in different organs and diseases (Fig. 1).
Keyphrases
- growth factor
- heart failure
- healthcare
- cardiovascular disease
- public health
- dendritic cells
- stem cells
- oxidative stress
- mental health
- bone marrow
- health information
- endothelial cells
- acute myeloid leukemia
- gene expression
- multiple sclerosis
- mesenchymal stem cells
- left ventricular
- type diabetes
- health promotion
- microbial community
- wound healing
- soft tissue
- coronary artery disease
- wastewater treatment
- metabolic syndrome
- peripheral blood
- social media
- drug induced
- antibiotic resistance genes
- pluripotent stem cells